Evidence map›Paper›PMID 29748492›Full record

ArticleGenes2018

Transcription Factor Binding Site Enrichment Analysis in Co-Expression Modules in Celiac Disease.

Irati Romero-Garmendia, Koldo Garcia-Etxebarria, Hector Hernandez-Vargas, Izortze Santin, Amaia Jauregi-Miguel, Leticia Plaza-Izurieta, Marie-Pierre Cros, Maria Legarda, Iñaki Irastorza, Zdenko Herceg and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Irati Romero-GarmendiaUniversity of the Basque Country (UPV-EHU) and Biocruces Health Research Institute, 48940 Leioa, Spain. irati.romero@ehu.eus.
Koldo Garcia-EtxebarriaUniversity of the Basque Country (UPV-EHU) and Biocruces Health Research Institute, 48940 Leioa, Spain. koldo.garcia@biodonostia.org.ORCID 0000-0002-6107-9416
Hector Hernandez-VargasEpigenetics Group, International Agency for Research on Cancer (IARC), 69372 Lyon CEDEX 08, France. hector.hernandez-vargas@lyon.unicancer.fr.ORCID 0000-0001-6045-2103
Izortze SantinUniversity of the Basque Country (UPV-EHU) and Biocruces Health Research Institute, 48940 Leioa, Spain. izortze.santingomez@osakidetza.eus.ORCID 0000-0003-1651-6776
Amaia Jauregi-MiguelUniversity of the Basque Country (UPV-EHU) and Biocruces Health Research Institute, 48940 Leioa, Spain. amaia.jauregimiguel@gmail.com.
Leticia Plaza-IzurietaUniversity of the Basque Country (UPV-EHU) and Biocruces Health Research Institute, 48940 Leioa, Spain. immunogenetics.let@gmail.com.
Marie-Pierre CrosEpigenetics Group, International Agency for Research on Cancer (IARC), 69372 Lyon CEDEX 08, France. crosm@iarc.fr.
Maria LegardaPediatric Gastroenterology Unit, Cruces University Hospital, University of the Basque Country-(UPV/EHU) and Biocruces Health Research Institute, 48903 Barakaldo, Spain. maria.legardatamara@osakidetza.net.
Iñaki IrastorzaPediatric Gastroenterology Unit, Cruces University Hospital, University of the Basque Country-(UPV/EHU) and Biocruces Health Research Institute, 48903 Barakaldo, Spain. inakixarles.irastorzaterradillos@osakidetza.net.
Zdenko HercegEpigenetics Group, International Agency for Research on Cancer (IARC), 69372 Lyon CEDEX 08, France. hercegz@iarc.fr.
Nora Fernandez-JimenezUniversity of the Basque Country (UPV-EHU) and Biocruces Health Research Institute, 48940 Leioa, Spain. nora.fernandez@ehu.eus.
Jose Ramon BilbaoUniversity of the Basque Country (UPV-EHU) and Biocruces Health Research Institute, 48940 Leioa, Spain. joseramon.bilbao@ehu.eus.ORCID 0000-0002-3176-501X
University of the Basque Country · ESCentre international de recherche sur le cancer · FR

Funding

World Health Organization 001
6 · The paper itself

Abstract

The aim of this study was to construct celiac co-expression patterns at a whole genome level and to identify transcription factors (TFs) that could drive the gliadin-related changes in coordination of gene expression observed in celiac disease (CD). Differential co-expression modules were identified in the acute and chronic responses to gliadin using expression data from a previous microarray study in duodenal biopsies. Transcription factor binding site (TFBS) and Gene Ontology (GO) annotation enrichment analyses were performed in differentially co-expressed genes (DCGs) and selection of candidate regulators was performed. Expression of candidates was measured in clinical samples and the activation of the TFs was further characterized in C2BBe1 cells upon gliadin challenge. Enrichment analyses of the DCGs identified 10 TFs and five were selected for further investigation. Expression changes related to active CD were detected in four TFs, as well as in several of their in silico predicted targets. The activation of TFs was further characterized in C2BBe1 cells upon gliadin challenge, and an increase in nuclear translocation of CAMP Responsive Element Binding Protein 1 (CREB1) and IFN regulatory factor-1 (IRF1) in response to gliadin was observed. Using transcriptome-wide co-expression analyses we are able to propose novel genes involved in CD pathogenesis that respond upon gliadin stimulation, also in non-celiac models.

Indexed as

celiac diseaseco-expressioncomplex diseasegene regulationtranscription factor

Identifiers

PMID29748492
PMCPMC5977185
OpenAlexW2800045622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.